Lucy Fraiser

565 total citations
6 papers, 457 citations indexed

About

Lucy Fraiser is a scholar working on Pathology and Forensic Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Lucy Fraiser has authored 6 papers receiving a total of 457 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Pathology and Forensic Medicine, 2 papers in Oncology and 1 paper in Molecular Biology. Recurrent topics in Lucy Fraiser's work include Chemotherapy-induced organ toxicity mitigation (3 papers), Polyomavirus and related diseases (2 papers) and Risk and Safety Analysis (1 paper). Lucy Fraiser is often cited by papers focused on Chemotherapy-induced organ toxicity mitigation (3 papers), Polyomavirus and related diseases (2 papers) and Risk and Safety Analysis (1 paper). Lucy Fraiser collaborates with scholars based in United States. Lucy Fraiser's co-authors include James P. Kehrer, Sarathchandra Kanekal, Tamer Ahmed and Blain Mamiya and has published in prestigious journals such as Drugs, Toxicology and Applied Pharmacology and Toxicology.

In The Last Decade

Lucy Fraiser

6 papers receiving 439 citations

Peers

Lucy Fraiser
Sarathchandra Kanekal United States
Lucy Fraiser
Citations per year, relative to Lucy Fraiser Lucy Fraiser (= 1×) peers Sarathchandra Kanekal

Countries citing papers authored by Lucy Fraiser

Since Specialization
Citations

This map shows the geographic impact of Lucy Fraiser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lucy Fraiser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lucy Fraiser more than expected).

Fields of papers citing papers by Lucy Fraiser

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lucy Fraiser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lucy Fraiser. The network helps show where Lucy Fraiser may publish in the future.

Co-authorship network of co-authors of Lucy Fraiser

This figure shows the co-authorship network connecting the top 25 collaborators of Lucy Fraiser. A scholar is included among the top collaborators of Lucy Fraiser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lucy Fraiser. Lucy Fraiser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
1.
Fraiser, Lucy. (2014). EPA May Go Beyond Law and Science in Setting NAAQS. 31(3). 1–8. 1 indexed citations
2.
Fraiser, Lucy, et al.. (2010). COMPARISON OF INTERNATIONAL RISK-BASED SCREENING LEVELS. ScholarWorks@UMassAmherst (University of Massachusetts Amherst). 15(1). 24. 8 indexed citations
3.
Fraiser, Lucy, et al.. (1995). Acrolein Mercapturates: Synthesis, Characterization, and Assessment of Their Role in the Bladder Toxicity of Cyclophosphamide. Chemical Research in Toxicology. 8(4). 515–524. 41 indexed citations
4.
Fraiser, Lucy & James P. Kehrer. (1992). Murine strain differences in metabolism and bladder toxicity of cyclophosphamide. Toxicology. 75(3). 257–272. 31 indexed citations
5.
Kanekal, Sarathchandra, Lucy Fraiser, & James P. Kehrer. (1992). Pharmacokinetics, metabolic activation, and lung toxicity of cyclophosphamide in C57B16 and ICR mice. Toxicology and Applied Pharmacology. 114(1). 1–8. 23 indexed citations
6.
Fraiser, Lucy, Sarathchandra Kanekal, & James P. Kehrer. (1991). Cyclophosphamide Toxicity. Drugs. 42(5). 781–795. 353 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026